T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg/Th17 balance.
Yang X, Zhou F, Yuan P, Dou G, Liu X, Liu S, Wang X, Jin R, Dong Y, Zhou J, Lv Y, Deng Z, Liu S, Chen X, Han Y, Jin Y.
Yang X, et al. Among authors: lv y.
Bioact Mater. 2021 Mar 10;6(10):3150-3163. doi: 10.1016/j.bioactmat.2021.02.034. eCollection 2021 Oct.
Bioact Mater. 2021.
PMID: 33778195
Free PMC article.